- AbbVie reported 3Q international Humira revenue of $311 million.
- AbbVie reported third-quarter international Humira revenue of $311 million, according to a Dow Jones Newswires data point. The figure is part of the company's Q3 earnings release.
AbbVie's third-quarter international Humira revenue came in at $311 million. The figure reflects continued pressure from biosimilar competition on the company's former blockbuster drug.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.